Anastrozole Anazol 1mg Tablets

Get a Price/Quote

MOQ : 10 Pieces

Anastrozole Anazol 1mg Tablets Specification

Indication
Breast cancer treatment in postmenopausal women

Salt Composition
Anastrozole 1mg

Dosage Form
Tablet

Feature
Highly effective aromatase inhibitor for hormone receptor positive breast cancer

Ingredients
Anastrozole and excipients

Application
Oral anti-cancer medication

Physical Color/Texture
White or off-white tablets, film-coated

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, in a dry place, away from light

Shelf Life
24 to 36 months

Prescription Required
Yes

Administration Route
Oral

Usage Duration
As directed by the physician

Marketed By
Defined on packaging (local manufacturer/distributor)

Patient Group
Postmenopausal women

Regulatory Approval
IP (Indian Pharmacopoeia) standard

Brand Name
ANAZOL

Caution
Not recommended for premenopausal women or men

Dose Strength
1mg per tablet

Export Markets
Canada, Europe, UK, USA, Australia

Packaging Size
Box of 10 tablets

Anastrozole Anazol 1mg Tablets About

Step into the spotlight and seize the splendid deal on ANAZOL Anastrozole 1mg Tablets-crafted to meet venerable IP (Indian Pharmacopoeia) standards. This limited stock offer brings ravishing support for postmenopausal women battling hormone receptor-positive breast cancer. Each film-coated, white or off-white tablet delivers assured efficacy as an aromatase inhibitor and is designed for oral administration-only upon prescription. Packaged in convenient boxes of 10, ANAZOL is trusted for export across Canada, Europe, the UK, the USA, and Australia. Store below 25C, away from light, to preserve its full potential.

Highlighted Use & Distinguishing Features

ANAZOL Anastrozole 1mg Tablets are specifically formulated for postmenopausal women diagnosed with hormone receptor-positive breast cancer. Used under a physician's guidance, this oral anti-cancer medication offers a highly effective approach in hormone therapy. The tablets are film-coated, odorless, and present a trusted choice due to their adherence to venerable IP standards. Not recommended for premenopausal women or men, ANAZOL stands out for its reliability and proven suitability among leading therapies.

FOB Port & Global Export Logistics

ANAZOL Anastrozole 1mg Tablets are dispatched efficiently from major Indian FOB ports, ensuring prompt transportation and delivery. The supply ability matches high domestic and international demand, with consistent distribution across key export markets including the USA, UK, Canada, Australia, and Europe. Each consignment is securely packaged to preserve tablet quality. With competitive logistics, these tablets reach patients and healthcare institutions worldwide, reinforcing India's standing as a trusted supplier and trader in the domestic and global market.

FAQ's of Anastrozole Anazol 1mg Tablets:

Q: How are Anastrozole Anazol 1mg Tablets administered?

A: Anastrozole Anazol 1mg Tablets are taken orally, usually once a day, as prescribed by your physician. Always follow your doctor's instructions regarding dosage and duration.

Q: What is the primary use of ANAZOL Anastrozole 1mg Tablets?

A: These tablets are indicated for the treatment of hormone receptor-positive breast cancer specifically in postmenopausal women, working as an aromatase inhibitor.

Q: When should I avoid taking Anastrozole Anazol tablets?

A: ANAZOL is not recommended for premenopausal women or men. Consult your healthcare provider before use if you have any concerns or pre-existing conditions.

Q: Where are ANAZOL Anastrozole Tablets manufactured and exported?

A: ANAZOL is manufactured in India and exported to major markets including Canada, the UK, USA, Europe, and Australia.

Q: What are the storage instructions for these tablets?

A: Store the tablets below 25C in a dry place and keep them away from light to maintain their stability over the 24 to 36-month shelf life.

Q: What benefits do Anastrozole Anazol 1mg Tablets provide?

A: They offer a highly effective option for hormone therapy in postmenopausal women with hormone receptor-positive breast cancer, helping to inhibit disease progression under physician supervision.

Tell us about your requirement